Training the Innate Immune System Against SARS-COV-2 (COVID-19) Using the Shingrix Vaccine in Nursing Home Residents: A Randomized, Doubled-Blinded, Comparative Group Observational Study
Latest Information Update: 24 Nov 2023
At a glance
- Drugs GSK 137173A (Primary) ; AS01B
- Indications COVID 2019 infections; Herpes zoster
- Focus Pharmacodynamics
- Acronyms NH-Shingrix
- 20 Nov 2023 Status changed from active, no longer recruiting to completed.
- 07 Dec 2021 Planned End Date changed from 30 Dec 2021 to 30 Sep 2022.
- 07 Dec 2021 Status changed from recruiting to active, no longer recruiting.